Birchview Capital, LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,837,000
-21.6%
10,672
-42.8%
1.25%
-10.8%
Q2 2021$2,343,000
-7.5%
18,6720.0%1.40%
-6.7%
Q1 2021$2,532,000
+6.0%
18,6720.0%1.50%
+9.2%
Q4 2020$2,389,000
-43.1%
18,672
-50.0%
1.38%
-2.0%
Q3 2020$4,202,000
+136.2%
37,344
+100.0%
1.40%
+30.6%
Q2 2020$1,779,000
+6.0%
18,6720.0%1.08%
-27.8%
Q1 2020$1,678,000
+69.5%
18,6720.0%1.49%
+106.7%
Q4 2019$990,000
+34.1%
18,6720.0%0.72%
+46.3%
Q3 2019$738,000
-3.8%
18,6720.0%0.49%
+5.6%
Q2 2019$767,000
-11.8%
18,6720.0%0.47%
-14.5%
Q1 2019$870,000
+7.0%
18,6720.0%0.54%
-29.1%
Q4 2018$813,000
+18.3%
18,672
+55.6%
0.77%
+73.6%
Q3 2018$687,000
+18.0%
12,0000.0%0.44%
+11.9%
Q2 2018$582,000
-40.5%
12,000
-52.0%
0.40%
-38.5%
Q1 2018$978,000
-7.8%
25,0000.0%0.64%
+3.5%
Q4 2017$1,061,000
+13.7%
25,0000.0%0.62%
+29.0%
Q3 2017$933,000
+104.6%
25,000
+66.7%
0.48%
+100.0%
Q2 2017$456,00015,0000.24%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders